ClinFAST Advantage ClinFAST launch signals a rapid fill/finish solution for clinical trial supplies, presenting a collaboration opportunity to biotech and pharma clients seeking speed to clinic and on-time, in-full delivery.

Aseptic Capacity New APS-qualified facility in Spokane with advanced fill/finish capacity and harmonized GMP compliance positions Selkirk as a scalable partner for injectable biologics, vaccines, and sterile products.

Ultra‑High Efficiency State‑of‑the‑art equipment like the VarioSys filler with SKAN isolator technology enables high-yield production and reliable aseptic processing, appealing to manufacturers aiming to optimize throughput and quality.

Strategic Growth Significant recent funding and facility investments, alongside new leadership, indicate a growth trajectory and expanding capabilities that can support customers with increasing demand and longer development pipelines.

Regulatory Readiness Dedicated in-house analytical, microbiology, and regulatory support plus real-time QA review facilitate compliance for US FDA and EU Annex 1, making Selkirk attractive for partners needing stringent quality and fast regulatory alignment.